Skip to main content

Table 4 Median estimated disease-specific survival, 5-year disease-specific survival and 10-year disease-specific survival from inital treatment and from the time of diagnosis of metastatic disease

From: Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience

  From the initial treatment From the diagnosis of distant metastases
  Estimated median length of survival (months) Estimated 5-year disease-specific survival (%) Estimated 10-year disease-specific survival (%) Estimated median length of survival (months) Estimated 5-year disease-specific survival (%) Estimated 10-year disease-specific survival (%)
All patients 145 81 60 77 54 40
Pulmonary metastases all patients 141 81 60 72 52 31
≤3 pulmonary metastases 100 67 44 32 27 -
>3 pulmonary metastases 141 77 55 76 70 35
Without pulmonary metastases 153 74 62 138 55 37
Bone metastases 148 70 68 148 70 50
Single organ metastases 131 77 52 72 58 37
Multiple organ metastases 145 100 100 93 70 38
Initially metastatic 141 76 52 141 76 52
Metastatic after disease-free interval 145 81 60 65 44 19
\